Scientists in the polo-obsessed nation have produced world's first genetically edited horses, designed to outrun champion ...

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

The Trump administration's plan to cut billions of dollars from National Institutes of Health funding would devastate ...

Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical ...

South by Southwest has announced new keynotes and its latest round of featured speakers, including Issa Rae, Conan O'Brien and Kevin Bacon.

Zacks Research decreased their Q1 2025 EPS estimates for CRISPR Therapeutics in a report issued on Wednesday, February 5th. Zacks Research analyst R. Department now anticipates that the company will ...

Jones Trading initiated coverage on ProQR Therapeutics N.V. (NASDAQ:PRQR) with a Buy rating and set a price target of $11.00, representing significant upside from the current price of $2.19. The ...

Executive Deputy of the Centre for Food Safety and Agricultural Research (CEFSAR), Prof. Qrissturberg Amua, has made a passionate appeal to the President of the Senate, Senator Godswill Akpabio and ...

The Trump administration's plan to cut billions of dollars from National Institutes of Health funding would devastate California universities, California Attorney General Rob Bonta and fellow ...

Inc. has seen its stock tumble to a 52-week low, touching down at $1.12. With a current market capitalization of just $93 million, the company maintains a strong liquidity position with a current ...